Tag Archives: Policy

Alliance of Defence Service Organisations – Advocacy for Australian Mefloquine and Tafenoquine Veterans

The Alliance of Defence Service Organisations (ADSO) comprises 14 organisations that represent the interests of serving Australian Defence Force personnel and veterans, totalling around 100,000 members. Their key role is to provide national advocacy and representation to the Australian Federal Parliament … Continue reading

Posted in Advocacy, Support | Tagged , , , , | Leave a comment

Loren Ries – Counting the Cost of Human Trials

This post was recently written by Loren Ries, the proud and accomplished wife of an Australian Army mefloquine & tafenoquine veteran, re-published with kind permission from her blog Loren Land. When you think of human trials and the military, what … Continue reading

Posted in Clinical Drug Trials, Our Stories | Tagged , , , , , , , , | Leave a comment

Mefloquine – Findings of the Senate Inquiry into the Mental Health of Australian Defence Force Serving Personnel

On 25 March 2015 the Australian Senate initiated an inquiry into the mental health of Australian Defence Force serving personnel. The Committee heard testimony from Major Stuart McCarthy and Dr Jane Quinn on the adverse health impacts of mefloquine on … Continue reading

Posted in Advocacy, Clinical Drug Trials | Tagged , , , , , , | 5 Comments

2015 in review

The WordPress.com statisticians prepared a 2015 annual report for this blog.   Here’s an excerpt: The concert hall at the Sydney Opera House holds 2,700 people. This blog was viewed about 14,000 times in 2015. If it were a concert … Continue reading

Posted in Advocacy, Media, Our Stories, Research, Roll of Honour | Tagged , , , , , , , , | Leave a comment

Statement by Major Stuart McCarthy on Extensive Criminal Misconduct by Senior Australian Defence Force Officials

The Australian Defence Human Research Ethics Committee (ADHREC) minutes reported by The Australian and The Sydney Morning Herald this morning provide further damning evidence of the extensive harm caused to Australian soldiers by the unethical drug trials conducted by the Army Malaria Institute … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media | Tagged , , , , , , , , | 29 Comments

Dr Jane Quinn – Busting the Nameless MoD ‘Mythbusters’

The UK ministry of Defence (MoD) recently published a so-called ‘mythbusting guide‘ to the use of Lariam in the British forces. The piece written by an unnamed, faceless blogger made a number of false claims, including: “The [Public Health England Advisory … Continue reading

Posted in Advocacy, Media, Research | Tagged , , , , , , , , , , , | Leave a comment

Feature Story – Answers Sought Over Army’s Use of Malaria Drug Mefloquine (Sima Kotecha, BBC)

“How can it be that we have a situation where this loyalty and duty of care that should be delivered by the surgeon general and the defence chiefs is a complete deficit?”  Lieutenant Colonel Andrew Marriott MBE (retd) There are … Continue reading

Posted in Advocacy, Media, Our Stories | Tagged , , , , , , , , , , , , , , | Leave a comment

Featured Research – Remington L. Nevin, Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine Policy

Abstract “Mefloquine is an antimalarial drug that has been commonly used in military settings since its development by the US military in the late 1980s. Owing to the drug’s neuropsychiatric contraindications and its high rate of inducing neuropsychiatric symptoms, which … Continue reading

Posted in Research | Tagged , , , , , , , , | Leave a comment